Future Innovations in Pediatric Medicine: 3D Printing Tablets for Toxoplasmosis Treatment
Future Innovations in Pediatric Medicine
Texas A&M researchers are pioneering exciting advancements in pediatric care by creating 3D printed tablets specifically designed for children. This innovative approach aims to replace high-cost adult tablets traditionally used to treat toxoplasmosis, a parasitic infection impacting millions globally.
The Challenge of Toxoplasmosis
Toxoplasmosis is a leading cause of foodborne deaths in the United States, particularly dangerous for pregnant women as it can be transmitted to the fetus. It is estimated that over 40 million people in the US and approximately 1 billion worldwide are infected with Toxoplasma gondii.
Addressing Pediatric Needs
Currently, adult tablets are often compounded for pediatric prescriptions, leading to potential concerns regarding quality and efficacy since these products have not been rigorously evaluated for content, stability, and bioavailability. The introduction of 3D printed tablets signifies a monumental shift towards tailored, quality medications for pediatric patients.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.